Anastasia Milusev, Jianfang Ren, Alain Despont, Jane Shaw, Matthias Längin, Martin Bender, Jan-Michael Abicht, Maren Mokelke, Julia Radan, Elisabeth Neumann, Elisabeth Kemter, Nikolai Klymiuk, David Ayares, Eckhard Wolf, Bruno Reichart, Nicoletta Sorvillo, Robert Rieben
Xenotransplantation is a promising approach to reduce organ shortage, while genetic modification of donor pigs has significantly decreased the immunogenic burden of xenotransplants, organ rejection is still a hurdle. Genetically modified pig organs are used in xenotransplantation research, and the first clinical pig-to-human heart transplantation was performed in 2022. However, the impact of genetic modification has not been investigated on a cellular level yet. Endothelial cells (EC) and their sugar-rich surface known as the glycocalyx are the first barrier encountering the recipient's immune system, making them a target for rejection...
2023: Xenotransplantation